NuCana (NCNA) vs XTL Biopharmaceuticals (XTLB)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
XTL Biopharmaceuticals is the larger company by market cap ($4.8 million vs $4.6 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Head-to-head
| Metric | NCNA | XTLB |
|---|---|---|
| Share price | $1.12 | $1.97 |
| Market cap | $4.64M | $4.84M |
| 1-day change | -2.19% | -0.51% |
| EPS (TTM) | $0.00 | $-0.36 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $6.40 | $7.44 |
| 52-week low | $0.948 | $1.97 |
| Distance from 52-week high | -82.58% | -73.52% |
| Average volume | 123.99K | 8.49K |
| Shares outstanding | 4.16M | 2.46M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
NCNA vs XTLB FAQ
Which is bigger, NuCana or XTL Biopharmaceuticals?
XTL Biopharmaceuticals (XTLB) is larger, with a market capitalization of $4.84M compared with $4.64M for NuCana (NCNA).
Are NuCana and XTL Biopharmaceuticals in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.